Low dose erythropoietin in maintenance haemodialysis: improvement in quality of life and reduction in true cost of haemodialysis (Q43835819)

27 November 2017

Low dose erythropoietin in maintenance haemodialysis: improvement in quality of life and reduction in true cost of haemodialysis (English)

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1991.TB01372.X

17 November 2022

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1991.TB01372.X

17 November 2022

author name string

D. C. Harris

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1759917

17 November 2022

J. R. Chapman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1759917

17 November 2022

J. H. Stewart

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1759917

17 November 2022

S. Lawrence

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1759917

17 November 2022

S. D. Roger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1759917

17 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1759917

17 November 2022

publication date

1 October 1991

1 reference

full work available at URL

27 November 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1445-5994.1991.tb01372.x

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1991.TB01372.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1445-5994.1991.tb01372.x/fullpdf

17 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1991.TB01372.X

Australian and New Zealand journal of medicine

17 November 2022

published in

1 reference

27 November 2017

21

1 reference

27 November 2017

5

1 reference

27 November 2017

693-700

1 reference

Beneficial effects of erythropoietin on haematological parameters, aerobic capacity, and body fluid composition in patients on haemodialysis

27 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1991.TB01372.X

Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1991.TB01372.X

Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial

17 November 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1991.TB01372.X

Beneficial and adverse effects of correction of anaemia by recombinant human erythropoietin in patients on maintenance haemodialysis

17 November 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1991.TB01372.X

Quality of life: subjective and objective improvements with recombinant human erythropoietin therapy

17 November 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1991.TB01372.X

Treating renal anaemia with recombinant human erythropoietin: practical guidelines and a clinical algorithm

17 November 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1991.TB01372.X

Desferrioxamine enhances the haemopoietic response to erythropoietin, but adverse events are common

17 November 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1991.TB01372.X

Measuring disease-specific quality of life in clinical trials

17 November 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1991.TB01372.X

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

17 November 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1991.TB01372.X

The functional status of ESRD patients as measured by the Sickness Impact Profile.

17 November 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1991.TB01372.X

The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure

17 November 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1991.TB01372.X

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

17 November 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1991.TB01372.X

Cost-effectiveness of weekly and fortnightly subcutaneous erythropoietin.

17 November 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1991.TB01372.X

Effects of recombinant human erythropoietin on HLA sensitization and cell mediated immunity

17 November 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1991.TB01372.X

17 November 2022

Identifiers

1 reference

release_go5lqzpvknbplcejbne2dppbfm

27 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/go5lqzpvknbplcejbne2dppbfm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference